Table:
Characteristic	Value
Age (years)
Median	73
Range	42-89
Tumor size (cm)
Median	1.0
Range	0.1-3.5
Histology
Invasive ductal	213 (68%)
Invasive lobular	31 (10%)
DCIS	68 (22%)
Grade
Grade 1	142 (46%)
Grade 2	114 (37%)
Grade 3	53 (17%)
Not stated	3 (1%)
Invasive tumors - EIC present
Yes	34 (14%)
No	206 (84%)
Not stated	4 (2%)
Invasive tumors - LVI present
Yes	5 (2%)
No	235 (96%)
Not stated	4 (2%)
DCIS tumors - Necrosis present
Yes	36 (53%)
No	28 (41%)
Not stated	4 (6%)
Nodal Status of invasive cancer
N0	207 (85%)
N1	2 (1%)
Nx	35 (14%)
ER/PR status
Positive	282 (90%)
Negative	23 (7%)
Not stated	7 (2%)
HER-2/neu status of invasive cancer
Positive	11 (5%)
Negative	231 (95%)
Not stated	2 (1%)
Surgical margins
Negative (≥ 2 mm)	264 (85%)
Close (< 2 mm)	41 (13%)
Positive	7 (2%)
Chemotherapy
Yes	7 (2%)
No	305 (98%)
Hormonal therapy
Yes	166 (53%)
No	146 (47%)

What are the following figure content in markdown style: | Characteristic | Value | 
 | --- | --- | 
 | Age (years) |  | 
 | Median | 73 | 
 | Range | 42-89 | 
 | Tumor size (cm) |  | 
 | Median | 1.0 | 
 | Range | 0.1-3.5 | 
 | Histology |  | 
 | Invasive ductal | 213 (68%) | 
 | Invasive lobular | 31 (10%) | 
 | DCIS | 68 (22%) | 
 | Grade |  | 
 | Grade 1 | 142 (46%) | 
 | Grade 2 | 114 (37%) | 
 | Grade 3 | 53 (17%) | 
 | Not stated | 3 (1%) | 
 | Invasive tumors - EIC present |  | 
 | Yes | 34 (14%) | 
 | No | 206 (84%) | 
 | Not stated | 4 (2%) | 
 | Invasive tumors - LVI present |  | 
 | Yes | 5 (2%) | 
 | No | 235 (96%) | 
 | Not stated | 4 (2%) | 
 | DCIS tumors - Necrosis present |  | 
 | Yes | 36 (53%) | 
 | No | 28 (41%) | 
 | Not stated | 4 (6%) | 
 | Nodal Status of invasive cancer |  | 
 | N0 | 207 (85%) | 
 | N1 | 2 (1%) | 
 | Nx | 35 (14%) | 
 | ER/PR status |  | 
 | Positive | 282 (90%) | 
 | Negative | 23 (7%) | 
 | Not stated | 7 (2%) | 
 | HER-2/neu status of invasive cancer |  | 
 | Positive | 11 (5%) | 
 | Negative | 231 (95%) | 
 | Not stated | 2 (1%) | 
 | Surgical margins |  | 
 | Negative (≥

2 mm) | 264 (85%) | 
 | Close (< 2 mm) | 41 (13%) | 
 | Positive | 7 (2%) | 
 | Chemotherapy |  | 
 | Yes | 7 (2%) | 
 | No | 305 (98%) | 
 | Hormonal therapy |  | 
 | Yes | 166 (53%) | 
 | No | 146 (47%) |